WebOct 4, 2024 · SOUTH SAN FRANCISCO, Calif. & CASTRES, France -- October 4, 2024 -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA) and Pierre Fabre today announced an … WebJan 10, 2024 · Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel in Phase 3 development for Epstein-Barr virus-driven post ...
Atara Biotherapeutics公司简介 - Moomoo
WebApr 14, 2024 · Summary. Atara Biotherapeutics recently updated that its lead program, tab-cel, remains on track despite the COVID-19 pandemic. Tab-cel is the most advanced allogeneic T-cell immunotherapy and, in ... WebMar 31, 2024 · Atara’s pipeline includes tab-cel ® (tabelecleucel), which is in Phase 3 development for patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disorder (EBV+ PTLD) as well as other EBV-associated hematologic malignancies and solid tumors, including nasopharyngeal carcinoma (NPC); T-cell … stihl 028 wood boss
Collaborations - Atara Biotherapeutics
WebAug 8, 2024 · Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel ® (tabelecleucel) in Phase 3 development for Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+ PTLD); ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment … WebDec 14, 2024 · Overall, tab-cel was well-tolerated in treatment-refractory and immunocompromised patients. Atara also reported combined long-term survival data from Phase 2 and multicenter EAP studies of tab-cel in a second oral presentation. Results show that across studies, patients who responded to tab-cel for treatment of EBV+ PTLD … Web© 2024 Atara Biotherapeutics, Inc. All rights reserved. stihl 029 chainsaw specifications